HY-107589A-5mg
|
MedChemexpress LLC
|
BIO5192 (hydrate)
|
|
COVID-19-immunoregulation
|
|
HY-107589A-1mL
|
MedChemexpress LLC
|
BIO5192 (hydrate) [CAS ] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-107589-10mg
|
MedChemexpress LLC
|
BIO5192 [CAS 327613-57-0]
|
|
COVID-19-immunoregulation
|
|
HY-107589-25mg
|
MedChemexpress LLC
|
BIO5192 [CAS 327613-57-0]
|
|
COVID-19-immunoregulation
|
|
HY-107589-5mg
|
MedChemexpress LLC
|
BIO5192 [CAS 327613-57-0]
|
|
COVID-19-immunoregulation
|
|
HY-107589-50mg
|
MedChemexpress LLC
|
BIO5192 [CAS 327613-57-0]
|
|
COVID-19-immunoregulation
|
|
HY-103348-10mg
|
MedChemexpress LLC
|
Boc-Asp(OMe)-fluoromethyl ketone [CAS 187389-53-3]
|
|
COVID-19-immunoregulation
|
|
HY-103348-100mg
|
MedChemexpress LLC
|
Boc-Asp(OMe)-fluoromethyl ketone [CAS 187389-53-3]
|
|
COVID-19-immunoregulation
|
|
HY-103348-25mg
|
MedChemexpress LLC
|
Boc-Asp(OMe)-fluoromethyl ketone [CAS 187389-53-3]
|
|
COVID-19-immunoregulation
|
|
HY-103348-5mg
|
MedChemexpress LLC
|
Boc-Asp(OMe)-fluoromethyl ketone [CAS 187389-53-3]
|
|
COVID-19-immunoregulation
|
|
HY-103348-50mg
|
MedChemexpress LLC
|
Boc-Asp(OMe)-fluoromethyl ketone [CAS 187389-53-3]
|
|
COVID-19-immunoregulation
|
|
HY-129453-5mg
|
MedChemexpress LLC
|
BOP (sodium) [CAS 1947348-42-6]
|
|
COVID-19-immunoregulation
|
|
HY-B0186B-10mg
|
MedChemexpress LLC
|
Cefoselis (sulfate) [CAS 122841-12-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0186B-100mg
|
MedChemexpress LLC
|
Cefoselis (sulfate) [CAS 122841-12-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0186B-5mg
|
MedChemexpress LLC
|
Cefoselis (sulfate) [CAS 122841-12-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0186B-50mg
|
MedChemexpress LLC
|
Cefoselis (sulfate) [CAS 122841-12-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0186B-1mL
|
MedChemexpress LLC
|
Cefoselis (sulfate) [CAS 122841-12-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B1117-250mg
|
MedChemexpress LLC
|
Cefoxitin (sodium) [CAS 33564-30-6]
|
|
COVID-19-immunoregulation
|
|
HY-B1117-1mL
|
MedChemexpress LLC
|
Cefoxitin (sodium) [CAS 33564-30-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0698A-10mg
|
MedChemexpress LLC
|
Ceftibuten (dihydrate) [CAS 118081-34-8]
|
|
COVID-19-immunoregulation
|
|
HY-B0698A-100mg
|
MedChemexpress LLC
|
Ceftibuten (dihydrate) [CAS 118081-34-8]
|
|
COVID-19-immunoregulation
|
|
HY-B0698A-5mg
|
MedChemexpress LLC
|
Ceftibuten (dihydrate) [CAS 118081-34-8]
|
|
COVID-19-immunoregulation
|
|
HY-B0698A-50mg
|
MedChemexpress LLC
|
Ceftibuten (dihydrate) [CAS 118081-34-8]
|
|
COVID-19-immunoregulation
|
|
HY-B0698A-1mL
|
MedChemexpress LLC
|
Ceftibuten (dihydrate) [CAS 118081-34-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B1046-500mg
|
MedChemexpress LLC
|
Clofazimine [CAS 2030-63-9]
|
|
COVID-19-immunoregulation
|
|